ArticleBMJ open2026
How the risk of suicide and non-suicidal self-injury is assessed, monitored and managed in randomised controlled trials of interventions for youth depression: a scoping review.
Article in BMJ open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesThis scoping review examines randomised controlled trials (RCTs) for young people with depression to explore three key questions: (1) Do RCTs for young people with depression exclude participants based on risk of suicide or self-harm? (2) How is this risk monitored throughout the course of the trial? and (3) When risk is identified, how is this risk managed throughout the RCT?
designThis project used a scoping review methodology and was conducted in accordance with guidance in the Preferred Reporting Items for Systematic reviews and Meta-Analyses statement. DATA SOURCES: Four electronic databases (PsycINFO, Ovid MEDLINE, PsychARTICLES and Embase) were searched with sets of search terms. ELIGIBILITY: Included studies were RCTs evaluating interventions for depressive symptoms in young people (age 18 or under). Studies published between 1988 and 2025, and in English, were included. DATA EXTRACTION: Papers retrieved were independently screened by two reviewers, first by title and abstract and then full text, in accordance with eligibility criteria. Relevant data were then extracted.
results89 studies were included. Of these, 55.06% (n=49) excluded young people at screening or baseline stages for risk of suicide or self-harm, with four studies excluding over 10% of participants. Overall, 40.45% (n=36) of studies reported monitoring risk during the trial, with the majority (n=24; 66.67%) using psychometric assessment. Most studies that monitored risk took an active approach to managing it, for example, through referral to external clinical services (n=12; 33.33%) or further clinical involvement from the trial team (n=9; 25%).
conclusionTo ensure that RCTs for young people with depression are reliable, safe and can be replicated in clinical settings, there needs to be greater clarity on risk procedures in trials and on the expectations of reporting and monitoring the risk of suicide or self-harm. TRIAL REGISTRATION NUMBER: The protocol was registered with the Open Science Framework prior to the implementation of the search strategy (https://osf.io/6dz5a; registration DOI: 10.17605/OSF.IO/6DZ5A).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.